One place where technology’s role as a catalyst for innovation is particularly evident is 3D printing. According to tech research company Gartner, we are in the beginnings of a “Digital Industrial Revolution” that threatens to reshape how physical goods are created and 3D printing is at the heart of it.
By 2018, 3D printing will result in the loss of at least US$100-billion per year in intellectual property globally
At least one major western manufacturer will claim to have had intellectual property (IP) stolen for a mainstream product by thieves using 3D printers who will likely reside in those same western markets rather than in Asia by 2015.
The plummeting costs of 3D printers, scanners and 3D modelling technology, combined with improving capabilities, says Gartner, makes the technology for IP theft more accessible to would-be criminals. Importantly, 3D printers do not have to produce a finished good in order to enable IP theft. The ability to make a wax mould from a scanned object, for instance, can enable the thief to produce large quantities of items that exactly replicate the original.
By 2016, 3D printing of tissues and organs (bioprinting) will cause a global debate about regulating the technology or banning it for both human and non-human use
The US Food and Drug Administration or comparable agency in a developed nation that is charged with evaluating all medical proposals will introduce guidelines that prohibit the bioprinting of life-saving 3D printed organs and tissues without its prior approval by end of 2015.
Bioprinting is the medical application of 3D printers to produce living tissue and organs. The day when 3D bioprinted human organs are readily available is drawing closer. The emergence of 3D bioprinting facilities with the ability to print human organs can leave people wondering what the effect of it will be on society. Beyond these questions, however, there is the reality of what 3D bioprinting means in helping people who need organs that are otherwise not readily available.